- Home
- BHVN vs JBGS Comparison
BHVN vs JBGS Comparison
Compare BHVN & JBGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHVN
- JBGS
- Stock Information
- Founded
- BHVN 2013
- JBGS 2016
- Country
- BHVN United States
- JBGS United States
- Employees
- BHVN N/A
- JBGS N/A
- Industry
- BHVN Biotechnology: Pharmaceutical Preparations
- JBGS Real Estate Investment Trusts
- Sector
- BHVN Health Care
- JBGS Real Estate
- Exchange
- BHVN Nasdaq
- JBGS Nasdaq
- Market Cap
- BHVN 1.4B
- JBGS 1.4B
- IPO Year
- BHVN 2017
- JBGS 2017
- Fundamental
- Price
- BHVN $13.50
- JBGS $19.54
- Analyst Decision
- BHVN Strong Buy
- JBGS Sell
- Analyst Count
- BHVN 14
- JBGS 2
- Target Price
- BHVN $58.85
- JBGS $16.00
- AVG Volume (30 Days)
- BHVN 1.6M
- JBGS 852.9K
- Earning Date
- BHVN 08-07-2025
- JBGS 07-29-2025
- Dividend Yield
- BHVN N/A
- JBGS 3.58%
- EPS Growth
- BHVN N/A
- JBGS N/A
- EPS
- BHVN N/A
- JBGS N/A
- Revenue
- BHVN N/A
- JBGS $520,825,000.00
- Revenue This Year
- BHVN $3.00
- JBGS N/A
- Revenue Next Year
- BHVN $59.97
- JBGS $2.71
- P/E Ratio
- BHVN N/A
- JBGS N/A
- Revenue Growth
- BHVN N/A
- JBGS N/A
- 52 Week Low
- BHVN $13.04
- JBGS $13.28
- 52 Week High
- BHVN $55.70
- JBGS $19.60
- Technical
- Relative Strength Index (RSI)
- BHVN 42.74
- JBGS 73.67
- Support Level
- BHVN $13.30
- JBGS $17.93
- Resistance Level
- BHVN $14.09
- JBGS $19.27
- Average True Range (ATR)
- BHVN 0.82
- JBGS 0.51
- MACD
- BHVN 0.05
- JBGS 0.13
- Stochastic Oscillator
- BHVN 19.74
- JBGS 97.66
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.
About JBGS JBG SMITH Properties
JBG SMITH Properties is a real estate investment trust based in the United States. It owns, operates, invests in, and develops real estate assets concentrated in amenity-rich, metro-served submarkets in and around Washington, DC. In addition, the company also provides fee-based real estate services to legacy funds through its third-party real estate services business. The operating segments of the company are commercial, multifamily, and third-party asset management and real estate services. It generates maximum revenue from the commercial segment.